Its reduced expression is linked to aggressive tumor behavior, as it targets pathways such as Notch1, Notch2, cyclin-dependent protein kinase-6 (CDK6), and proteins involved in Akt/mTOR and Wnt signaling [96,97]. This evidence concerns the gene CDK6 and neoplasm.